Evidence map›Paper›PMID 38875579›Full record

ArticleJMIR AI2024

Leveraging Machine Learning to Develop Digital Engagement Phenotypes of Users in a Digital Diabetes Prevention Program: Evaluation Study.

Danissa V Rodriguez, Ji Chen, Ratnalekha V N Viswanadham, Katharine Lawrence, Devin Mann

Registry-linked trialAbstract read
In one paragraph

Article in JMIR AI, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04773834 (A Randomized Control Trial to Study the Effects of Automated Physician Directed Messaging on Patient Engagement in a Digital Diabetes Prevention Program), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04773834 nacompletednot on this map

A Randomized Control Trial to Study the Effects of Automated Physician Directed Messaging on Patient Engagement in a Digital Diabetes Prevention Program

TypeinterventionalSponsorNYU Langone HealthRan2021 to 2025Enrolled551ConditionsPre DiabetesArmsDigital diabetes prevention program (dDPP), Adapted dDPP-EHR tool
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Danissa V RodriguezNew York University Grosman School of Medicine, New York, NY, United States.ORCID https://orcid.org/0000-0003-4642-6798
Ji ChenNew York University Grosman School of Medicine, New York, NY, United States.ORCID https://orcid.org/0000-0002-4856-0141
Ratnalekha V N ViswanadhamNew York University Grosman School of Medicine, New York, NY, United States.ORCID https://orcid.org/0000-0002-9786-2090
Katharine LawrenceNew York University Grosman School of Medicine, New York, NY, United States.ORCID https://orcid.org/0000-0001-5640-2138
Devin MannNew York University Grosman School of Medicine, New York, NY, United States.ORCID https://orcid.org/0000-0002-2099-0852

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDigital diabetes prevention programs (dDPPs) are effective "digital prescriptions" but have high attrition rates and program noncompletion. To address this, we developed a personalized automatic messaging system (PAMS) that leverages SMS text messaging and data integration into clinical workflows to increase dDPP engagement via enhanced patient-provider communication. Preliminary data showed positive results. However, further investigation is needed to determine how to optimize the tailoring of support technology such as PAMS based on a user's preferences to boost their dDPP engagement.

objectiveThis study evaluates leveraging machine learning (ML) to develop digital engagement phenotypes of dDPP users and assess ML's accuracy in predicting engagement with dDPP activities. This research will be used in a PAMS optimization process to improve PAMS personalization by incorporating engagement prediction and digital phenotyping. This study aims (1) to prove the feasibility of using dDPP user-collected data to build an ML model that predicts engagement and contributes to identifying digital engagement phenotypes, (2) to describe methods for developing ML models with dDPP data sets and present preliminary results, and (3) to present preliminary data on user profiling based on ML model outputs.

methodsUsing the gradient-boosted forest model, we predicted engagement in 4 dDPP individual activities (physical activity, lessons, social activity, and weigh-ins) and general activity (engagement in any activity) based on previous short- and long-term activity in the app. The area under the receiver operating characteristic curve, the area under the precision-recall curve, and the Brier score metrics determined the performance of the model. Shapley values reflected the feature importance of the models and determined what variables informed user profiling through latent profile analysis.

resultsWe developed 2 models using weekly and daily DPP data sets (328,821 and 704,242 records, respectively), which yielded predictive accuracies above 90%. Although both models were highly accurate, the daily model better fitted our research plan because it predicted daily changes in individual activities, which was crucial for creating the "digital phenotypes." To better understand the variables contributing to the model predictor, we calculated the Shapley values for both models to identify the features with the highest contribution to model fit; engagement with any activity in the dDPP in the last 7 days had the most predictive power. We profiled users with latent profile analysis after 2 weeks of engagement (Bayesian information criterion=-3222.46) with the dDPP and identified 6 profiles of users, including those with high engagement, minimal engagement, and attrition.

conclusionsPreliminary results demonstrate that applying ML methods with predicting power is an acceptable mechanism to tailor and optimize messaging interventions to support patient engagement and adherence to digital prescriptions. The results enable future optimization of our existing messaging platform and expansion of this methodology to other clinical domains.

trial registrationClinicalTrials.gov NCT04773834; https://www.clinicaltrials.gov/ct2/show/NCT04773834. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/26750.

Indexed as

chronic disease managementcommunicationdiabetesdigital diabetes prevention programsdigital healthdigital health interventiondigital phenotypesdigital prescriptionengagementevaluation studymachine learningmessaging platformsmobile healthpatient behaviorphenotypespreventionsupportuser engagementusers

Identifiers

PMID38875579
PMCPMC11041485

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.